Involvement of delta- and mu-opioid receptors in the potentiation of brain-stimulation reward (Q44344634)

2 December 2017

Involvement of delta- and mu-opioid receptors in the potentiation of brain-stimulation reward (English)

1 reference

2 December 2017

0 references

C Kornetsky

3

0 references

author name string

C L Duvauchelle

series ordinal

1

1 reference

PubMed ID

8982679

2 December 2017

S M Fleming

series ordinal

2

1 reference

PubMed ID

8982679

2 December 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

European Journal of Pharmacology

2 December 2017

1 reference

2 December 2017

316

1 reference

2 December 2017

2-3

1 reference

2 December 2017

137-143

1 reference

Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective mu and delta opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Kelatorphan, a potent enkephalinases inhibitor, and opioid receptor agonists DAGO and DTLET, differentially modulate self-stimulation behaviour depending on the site of administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Morphine lowering of self-stimulation thresholds: lack of tolerance with long-term administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Self-administration of methionine enkephalin into the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Opioid receptor subtypes associated with ventral tegmental facilitation of lateral hypothalamic brain stimulation reward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Comparison of delta opiate receptor agonist induced reward and motor effects between the ventral pallidum and dorsal striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Regional reward differences within the ventral pallidum are revealed by microinjections of a mu opiate receptor agonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Biphasic effects of intraaccumbens mu-opioid peptide agonist DAMGO on locomotor activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Behavioral effects of opioid peptide agonists DAMGO, DPDPE, and DAKLI on locomotor activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Reinforcing effects of morphine in the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

An approach to the design of receptor-type-selective nonpeptide antagonists of peptidergic receptors: .delta. opioid antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Naltrindole, an opioid delta receptor antagonist, blocks cocaine-induced facilitation of responding for rewarding brain stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900674-7

10.1016/S0014-2999(96)00674-7

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

8982679